Clinical Trial Update: Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of "HIV Units". [NA]

View source ↗

Summary

This clinical trial update describes implementing long-acting cabotegravir plus rilpivirine administration outside traditional HIV units after the study was com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• CABENUVA (cabotegravir and rilpivirine)
• cabotegravir (cabotegravir)
• rilpivirine (rilpivirine)

Snippet

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Conditions: HIV Infections | NA | Status: COMPLETED